SciELO - Scientific Electronic Library Online

 
vol.31 issue3Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosisProphylaxis with gentamicin locking of chronic tunneled central venous catheters does not cause bacterial resistance author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Nefrología (Madrid)

On-line version ISSN 1989-2284Print version ISSN 0211-6995

Abstract

PARRA MONCASI, E.  and  SOCIEDAD ESPANOLA DE NEFROLOGIA. Grupo de Gestión de la Calidad et al. Multicentre study of haemodialysis costs. Nefrología (Madr.) [online]. 2011, vol.31, n.3, pp.299-307. ISSN 1989-2284.

Background: Previous studies to determine the cost of haemodialysis (HD) in Spain have significant limitations: they are outdated or used indirect methods. There is also a lack of analysis performed simultaneously on Public centres (PC), with direct HD services, and partially state-subsidised centres (SC). This is an important issue since the two systems coexist in Spain. Objectives: To estimate the cost of HD replacement therapy for chronic renal failure in several centres. Methods: This is a prospective and publicly-funded study, which estimates the costs for 2008 using a cost accounting system with specific allocation criteria. We collected demographic and comorbidity data for each centre. Results: Six centres participated, two PC and four SC. There were no significant differences between centres in terms of patient demographics, time on haemodialysis and the Charlson comorbidity index. The total cost per patient per year ranged between €46 254 and €33 130. The cost per patient per year (excluding vascular access and hospital admission) for PC was €42 547 and €39 289 and for SC €32 872, €29 786, €35 461 and €35 294 (23% more in PC than SC). Costs related to staff/patient/year and consumables/patient/year were 67% and 83% respectively, higher for PC than SC. The highest percentage cost was for staff (average 30.9%), which showed significant variability between centres, both in absolute numbers (staff cost per patient per year between €18 151 and €8504) and as a percentage (between 42.6 % and 25.4%). Conclusions: Cost variability exists among different HD centres, and this can be attributed primarily to staff and consumables costs, which is higher for PC than SC.

Keywords : Cost; Haemodialysis; Dialysis; Renal failure.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License